Ramipril

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

ALTACE, ALTACE HCT, RAMACE – Sanofi-aventis Canada Inc. (NOC Search)

Patents:

1187087: NOVOPHARM, APOTEX, RIVA, TEVA, GENPHARM
1246457: PHARMASCIENCE, GENPHARM, APOTEX, NOVOPHARM, RIVA
1338344: APOTEX, PHARMASCIENCE
1341196: TEVA, RATIOPHARM, APOTEX, APOTEX, NOVOPHARM
1341206: APOTEX, PHARMASCIENCE, RANBAXY, RATIOPHARM, APOTEX, APOTEX, RATIOPHARM, TEVA, SANDOZ, COBALT, NOVOPHARM, GENPHARM, RIVA, PRO DOC, MYLAN
1341296: TEVA, NOVOPHARM
1341330: NOVOPHARM, APOTEX
2023089: PHARMASCIENCE, GENPHARM, APOTEX, NOVOPHARM, MYLAN, COBALT, RIVA
2055948: RIVA, MYLAN, SANDOZ, COBALT, APOTEX, NOVOPHARM, PHARMASCIENCE, GENPHARM
2382387: RIVA, MYLAN, COBALT, SANDOZ, APOTEX, NOVOPHARM, PHARMASCIENCE, GENPHARM
2382549: COBALT, SANDOZ, MYLAN, RIVA, PHARMASCIENCE, APOTEX, NOVOPHARM

APOTEX

PM(NOC) – A-1-07 (2007 FCA 342, 2007 FCA 7, 2007 FCA 71) – A-162-07 – A-404-06 – T-1237-09 – T-1465-03 – T-1499-04 (2007 FC 273) – T-1742-03 (2009 FC 51) – T-2189-06 – T-2196-06 (2006 FC 1559, 2007 FC 124) – T-748-09 – T-87-06
Infringement – T-161-07 (2007 FC 906, 2007 FC 907, 2008 FC 320, 2008 FC 628, 2009 FC 1138, 2009 FC 294, 2009 FC 676)
Section 8 – T-1357-09 (2009 FC 1285, 2010 FC 1209, 2012 FC 553)
Appeal – A-161-07 – A-179-09 – A-191-12 (2014 FCA 68) – A-193-12 – A-27-12 (2014 FCA 66) – A-321-12 – A-362-12 – A-386-09 – A-39-09 – A-390-09 – A-397-12 – A-431-05 – A-462-11 – A-472-12 – A-474-12 – A-485-09 (2012 FCA 265) – A-486-09 – A-576-08 (2008 FCA 394)

APOTEX, RATIOPHARM

Appeal – A-320-12 – A-419-07 (2008 FCA 175)

COBALT

Infringement – T-1615-08
PM(NOC) – T-1710-06

GENPHARM

PM(NOC) – T-1446-07
Infringement – T-1616-08

MYLAN

Infringement – T-787-13

NOVOPHARM

PM(NOC) – A-163-07 – A-607-06 (2007 FCA 167, 2007 FCA 384) – T-1965-05 (2009 FC 1003) – T-1979-05 (2006 FC 1473, 2006 FC 1547) – T-2188-06 (2007 FC 213) – T-997-07 – T-998-07
Infringement – T-1161-07 (2009 FC 1139, 2010 FC 1210, 2010 FC 150, 2012 FC 551, 2012 FC 552)
Other – T-2220-06
Appeal – A-387-09 – A-389-09 (2011 FCA 300) – A-413-06 (2006 FCA 362, 2007 FCA 163) – A-484-09 – A-489-09 – A-577-06

PHARMASCIENCE

PM(NOC) – A-422-06 – A-472-08 (2009 FCA 183) – A-555-07 (2008 FCA 213) – T-1029-09 – T-1348-09 (2010 FC 534) – T-2256-06 – T-2300-06 (2007 FC 1057, 2008 FC 782) – T-482-03 (2009 FC 915) – T-812-07 – T-837-07 (2008 FC 922)
Appeal – A-379-09 (2010 FCA 153)

PRO DOC

Infringement – T-1617-08

RANBAXY

Infringement – T-1614-08

RATIOPHARM, APOTEX

Appeal – A-126-08

RIVA

Appeal – A-288-07 – A-289-07
Infringement – T-1201-08 (2011 FC 1469)
PM(NOC) – T-127-07 (2007 FC 1317, 2007 FC 832, 2008 FC 291) – T-1384-04 (2007 FC 532) – T-1888-04 – T-584-08 – T-896-07

SANDOZ

PM(NOC) – T-233-07 – T-435-07 – T-436-07 – T-438-07
Infringement – T-1618-08

TEVA

Appeal – A-147-12 (2014 FCA 67) – A-192-12 (2014 FCA 69) – A-361-12 – A-369-10 – A-379-10 – A-406-10 – A-417-10 – A-418-10 – A-460-11 (2014 FCA 65) – A-468-11 – A-473-10 (2011 FCA 149)

Return to the Patented Medicine Litigation page.

Ramipril

Canadian Intellectual Property